Cardiovascular Dysfunction in Cirrhosis: Pathophysiological Evidence of a Cirrhotic Cardiomyopathy

References

• Kowalski HJ, Abelmann WH. The cardiac output at rest in Laënnecs cirrhosis. J Clin Invest 1953;32:1025–33.
   PubMed Web of Science ®Google Scholar
• Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958;24:358–67.
   Google Scholar
• Douglas Miller D, Burns RJ, Gill JB, Ruddy TD. Clinical cardiac imaging. New York: McGraw-Hill; 1988.
   Google Scholar
• Lieberman FL, Reynolds TB. Plasma volume in cirrhosis of the liver. Its relations to portal hypertension, ascites, and renal failure. J Clin Invest 1967;47:1297–308.
   Google Scholar
• Llach J, Ginés P, Arroyo V, Rimola A, Titó L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94:482–7.
   PubMed Web of Science ®Google Scholar
• Henriksen JH. Systemic haemodynamic alterations in hepatic cirrhosis. Eur J Gastroenterol Hepatol 1991;3:705–13.
   Web of Science ®Google Scholar
• Bosch J, Pizcueta MP, Fernandez M, Feu F, Cirera I, Luca A, et al. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension. In: Shields R, editor. Baillière’s clinical gastroenterology. Portal hypertension. London: Bail-lière Tindall; 1992. p. 425–36.
   Google Scholar
• Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver disease. In: Bosch J, Groszmann RJ, editors. Portal hypertension. Pathophysiology and treatment. Oxford: Blackwell; 1994. p. 17–26.
   Google Scholar
• Møller S, Wiinberg N, Henriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995;22: 88–95.
   Google Scholar
• Opie LH. The heart. Physiology, from cell to circulation, 3rd ed. Philadelphia: Lippincott; 1998.
   Google Scholar
• Parati G, Rienzo MD, Bertinieri G, Pomidossi G, Casadei R, Groppelli A, et al. Evaluation of the baroreceptor-heart reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension 1988;12:214–22.
   PubMed Web of Science ®Google Scholar
• Kumada M, Terui N, Kuwaki T. Arterial baroreceptor reflex: its central and peripheral neural mechanisms. Progr Neurobiol 1990;35:331–61.
   Google Scholar
• Braillon A, Cales P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986;27:1204–9.
   PubMed Web of Science ®Google Scholar
• Braillon A, Moreau R, Hadengue A, Roulot D, Sayegh R, Lebrec D. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol. J Hepatol 1989;9:312–8.
   PubMedGoogle Scholar
• Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989;97:1506–13.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral artery vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;5:1151–7.
   Google Scholar
• Sherlock S. Vasodilatation associated with hepatocellular disease: relation to functional organ failure. Gut 1990;31: 365–7.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Niederberger M, Weigert A, Gines P. Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis. Sem Liver Dis 1994;14:14–22.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Ginès P. Arteriolar vasodilatation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis. Gastroenterology 1992;102: 1077–9.
   PubMed Web of Science ®Google Scholar
• Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994;20: 1343–50.
   PubMed Web of Science ®Google Scholar
• Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776–8.
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen JH. Endothelins in chronic liver disease. Scand J Clin Lab Invest 1996;56:481–90.
   PubMed Web of Science ®Google Scholar
• Gupta S, Morgan TR, Gordan GS. Calcitonin gene-related peptide in hepatorenal syndrome. J Clin Gastroenterol 1992; 14:122–6.
   Google Scholar
• Guevara M, Ginès P, Jiménez W, Sort P, Fernandez-Esparrach G, Escorsell A, et al. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 1998;114:336–43.
   PubMed Web of Science ®Google Scholar
• Wong F, Blendis L. Natriuretic peptides: are these new links in the hepatorenal connections? Gut 1997;40:151–2.
   PubMedGoogle Scholar
• Chu CJ, Lee FY, Wang SS, Lu RH, Tsai YT, Lin HC, et al. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide. Clin Sci 1997;93:219–25.
   Google Scholar
• Eckberg DL, Sleight P. Human baroreflexes in health and disease. Oxford: Clarendon Press; 1992.
   Google Scholar
• Wong F, Logan A, Blendis L. Systemic hemodynamic, forearm vascular, renal, and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis. Hepatology 1995;21:717–24.
   Google Scholar
• Henriksen JH, Ring-Larsen H. Hepatorenal disorders: role of the sympathetic nervous system. Sem Liver Dis 1994;14:35–43.
   PubMed Web of Science ®Google Scholar
• Bernardi M, Trevisani F, Gasbarrini A, Gasbarrini G. Hepatorenal disorders. Role of the renin-angiotensin-aldosterone system. Sem Liver Dis 1994;14:23–34.
   Google Scholar
• Arroyo V, Claria J, Salo J, Jimenez W. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites. Sem Liver Dis 1994;14:44–58.
   PubMed Web of Science ®Google Scholar
• Colombato LA, Albillos A, Groszmann J. The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology 1996;110:193–8.
   Google Scholar
• Bernardi M, Fornale L, Dimarco C, Trevisani F, Baraldini M, Gasbarrini A, et al. Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. J Hepatol 1995;22:309–18.
   PubMed Web of Science ®Google Scholar
• Laffi G, Lagi A, Cipriani M, Barletta G, Bernardi L, Fattorini L, et al. Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. Hepatology 1996;24:1063–7.
   PubMed Web of Science ®Google Scholar
• Bernardi M, Gülberg V, Colantoni A, Trevisani F, Gasbarrini A, Gerbes AL. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol 1996;24:161–8.
   PubMed Web of Science ®Google Scholar
• Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. BMJ 1986; 292:1351–3.
   Google Scholar
• Wong F, Liu P, Allidina Y, Blendis L. The effect of posture on central blood volume in patients with preascitic cirrhosis on a sodium-restricted diet. Hepatology 1996;23:1141–7.
   PubMedGoogle Scholar
• MacGilchrist AJ, Reid JL. Impairment of autonomic reflexes in cirrhosis. Am J Gastroenterol 1990;85:288–92.
   PubMed Web of Science ®Google Scholar
• Hendrickse MT, Thuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992; 339:1462–4.
   Google Scholar
• Trevisani F, Sica G, Mainqu P, Santese G, De Notariis S, Caraceni P, et al. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology 1999;30:1387–92.
   PubMed Web of Science ®Google Scholar
• Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994;19:129–32.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Laiz JM, Banares R, Echenagusia A, Casado M, Camunez F, Perez-Roldan F, et al. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension: preliminary results. Dig Dis Sci 1995; 40:2121–7.
   Google Scholar
• Colombato LA, Spahr L, Martinet JP, Dufresne MP, Lafortune M, Fenyves D, et al. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996;39:600–4.
   PubMed Web of Science ®Google Scholar
• Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995;108:761–7.
   Google Scholar
• Niederberger M, Gines P, Martin PY, Tsai P, Morris K, Mcmurtry I, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 1996; 24:947–51.
   PubMed Web of Science ®Google Scholar
• Denie C, Vachiery F, Elman A, Soupison T, Gadano A, Moreau R, et al. Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasis. Liver 1996; 16:309–12.
   PubMedGoogle Scholar
• Cirera I, Elizalde JI, Pique JM, Feu F, Casadevall M, Goldin E, et al. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci 1997;42: 1697–702.
   PubMed Web of Science ®Google Scholar
• Lee WC, Lin HC, Hou MC, Lee FY, Chang FY, Tsai YT, et al. Effect of anaemia on haemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 1999;14:370–5.
   PubMed Web of Science ®Google Scholar
• Elizalde JI, Moitinho E, Garcia-Pagan JC, Cirera I, Escorsell A, Bandi JC, et al. Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients. J Hepatol 1998;29:789–95.
   Google Scholar
• Rector WG Jr, Hossack KF. Pathogenesis of sodium retention complicating cirrhosis: is there room for diminished ‘effective’ arterial blood volume? Gastroenterology 1988;95:1658–63.
   PubMedGoogle Scholar
• Dancy M, Bland JM, Leech G, Gaitonde MK, Maxwell JD. Preclinical left ventricular abnormalities in alcoholics are independent of nutritional status, cirrhosis and cigarette smoking. Lancet 1985;1:122–5.
   Google Scholar
• Wong F, Liu P, Tobe S, Morali G, Blendis L. Central blood volume in cirrhosi: measurement with radionuclide angiography. Hepatology 1994;19:312–21.
   Google Scholar
• Ahmed SS, Howard M, Hove Wt, Leevy CM, Regan TJ. Cardiac function in alcoholics with cirrhosis: absence of overt cardiomyopathy: myth or fact? JACC 1984;3:696–702.
   Google Scholar
• Kelbæk H, Eriksen J, Brynjolf I, Rabøl A, Lund JO, Munck O, et al. Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol 1984;54:852–5.
   Google Scholar
• Rector WG, Robertson AD, Lewis FW, Adair OV. Arterial underfilling does not cause sodium retention in cirrhosis. Am J Med 1993;95:286–95.
   PubMed Web of Science ®Google Scholar
• Rector WG Jr, Adair O, Hossack KF, Rainquet S. Atrial volume in cirrhosis: relatioship to blood volume and plasma concentrations of atrial natriuretic factor. Gastroenterology 1990;99:766–70.
   PubMedGoogle Scholar
• Friedman HS, Fernando H. Ascites as a marker for the hyperdynamic heart of Laennec’s cirrhosis. Alcohol Clin Exp Res 1992;16:968–70.
   PubMedGoogle Scholar
• Shah A, Variyam E. Pericardial effusion and left ventricular dysfunction associated with ascites secondary to hepatic cirrhosis. Arch Intern Med 1988;148:585–8.
   PubMedGoogle Scholar
• Keller H, Bezjak V, Stegaru B, Buss J, Holm E, Heene DL. Ventricular function in cirrhosis and portasystemic shunt: a two-dimensional echocardiographic study. Hepatology 1988; 8:658–62.
   PubMed Web of Science ®Google Scholar
• Estruch R, Fernandez-Sola J, Sacanella E, Pare C, Rubin E, Urbano-Marquez A. Relationship between cardiomyopathy and liver disease in chronic alcoholism. Hepatology 1995;22: 532–8.
   PubMedGoogle Scholar
• Laffi G, Barletta G, Lavilla G, Delbene R, Riccardi D, Ticali P, et al. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. Gastroenterology 1997;113:891–8.
   PubMed Web of Science ®Google Scholar
• Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, et al. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996;31:279–84.
   PubMed Web of Science ®Google Scholar
• Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997;26:1131–7.
   PubMed Web of Science ®Google Scholar
• Møller S, Søndergaard L, Møgelvang J, Henriksen O, Henriksen JH. Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. Hepatology 1995;22:472–8.
   PubMed Web of Science ®Google Scholar
• Lewis FW, Adair O, Rector WG. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992;102:1024–9.
   Google Scholar
• Friedman HS, Cirillo N, Schiano F, Nathan P, Khan S, Rosero H, et al. Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances. Alcohol Clin Exp Res 1995;19:123–9.
   PubMedGoogle Scholar
• Wong F, Liu P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999;97:259–67.
   Google Scholar
• Perello A, Inserte J, Godoy A, Puigfel Y, Garcia-Pagan JC, Garcia-Dorado D, et al. Cardiac structure and function in experimental intra-hepatic portal hypertension. J Hepatol 2000; 32 Suppl 2:65.
   Google Scholar
• Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology 1992;15:809–15.
   PubMedGoogle Scholar
• Meng HC, Lin HC, Tsai YT, Lee FY, Liao DM, Hsia HC, et al. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis. J Gastroenterol Hepatol 1994;9:148–53.
   PubMed Web of Science ®Google Scholar
• Gould L, Shariff M, Zahir M. Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop. J Clin Invest 1969;48:860–4.
   Google Scholar
• Gadano A, Hadengue A, Widmann JJ, Vachiery F, Moreau R, Yang S, et al. Hemodynamics after orthotopic liver transplantation: study of associated factors and long-term effects. Hepatology 1995;22:458–65.
   PubMed Web of Science ®Google Scholar
• Hadengue A, Kamal KB, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100:520–8.
   PubMed Web of Science ®Google Scholar
• Ruiz-Delarbol L, Monescillo A, Jimenez W, Garcia-Plaza A, Arroyo V, Rodes J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997;113:579–86.
   Google Scholar
• Agusti AGN, Roca J, Bosch J, Rodriguez-Roisin R. The lung in patients with cirrhosis. J Hepatol 1990;10:251–7.
   Google Scholar
• Rakela J, Krowka MJ. Cardiovascular and pulmonary complications of liver disease. In: Zakim D, Boyer TD, editors. Hepatology. A textbook of liver disease. Philadelphia: W.B. Saunders; 1996. p. 675–84.
   Google Scholar
• Kuo PC, Plotkin JS, Johnson LB, Howell CD, Laurin JM, Bartlett ST, et al. Distinctive clinical features of portopulmonary hypertension. Chest 1997;112:980–6.
   PubMed Web of Science ®Google Scholar
• Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997;25:1282–4.
   PubMedGoogle Scholar
• Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521–9.
   PubMedGoogle Scholar
• Krowka MJ. Hepatopulmonary syndrome. Transplant Proc 1993;25:1746–7.
   PubMedGoogle Scholar
• Krowka MJ. Pulmonary hypertension: diagnostics and therapeutics. Mayo Clin Proc 2000;75:625–30.
   PubMed Web of Science ®Google Scholar
• Kelbæk H, Rabøl A, Brynjolf I, Eriksen J, Bonnevie O, Godtfredsen J, et al. Haemodynamic response to exercise in patients with alcoholic liver cirrhosis. Clin Physiol 1987;7:35–41.
   PubMedGoogle Scholar
• Limas CJ, Guiha NH, Lekagul O. Impaired left ventricular function in alcoholic cirrhosis with ascites. J Lab Clin Med 1977;89:1175–87.
   Google Scholar
• Vachiery F, Moreau R, Gadano A, Yang S, Sogni P, Hadengue A, et al. Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker. Dig Dis Sci 1996;41:1722–6.
   PubMedGoogle Scholar
• McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, Mcintyre N, et al. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995;21:1255–60.
   PubMed Web of Science ®Google Scholar
• Escorsell A, Bandi JC, Moitinho E, Feu F, Garcia-Pagan JC, Bosch J, et al. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol 1997;26:621–7.
   Google Scholar
• Forrest EH, Bouchier IAD, Hayes PC. Acute effect of low-dose theophylline on the circulatory disturbances of cirrhosis. Gut 1997;40:139–44.
   Google Scholar
• Kakumitsu S, Shijo H, Yokoyama M, Kim T, Akiyoshi N, Ota K, et al. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis. Hepatology 1998;27:377–82.
   PubMedGoogle Scholar
• Vander-Linden P, Lemoine O, Ghysels M, Ortinez M, Deviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 1996;23:982–7.
   Google Scholar
• Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rossle M. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999;44:743–8.
   PubMed Web of Science ®Google Scholar
• Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts. Comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996; 25:135–44.
   Google Scholar
• Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999;29:632–9.
   Google Scholar
• Abelmann WH. Hyperdynamic circulation in cirrhosis: a historical perspective. Hepatology 1994;20:1356–8.
   PubMedGoogle Scholar
• Møller S. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis. Dan Med Bull 1998;45:1–14.
   PubMed Web of Science ®Google Scholar
• Gentilini P, Romanelli RG, Laffi G, Barletta G, Delbene R, Messeri G, et al. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 1999;30:632–8.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Polese A, Magrini F, Fiorentini C, Olivari MT. Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med 1975;59:165–70.
   Google Scholar
• Grose RD, Nolan J, Dillon JF, Errington M, Hannan WJ, Bouchier IAD, et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol 1995; 22:326–32.
   PubMed Web of Science ®Google Scholar
• Bernardi M, Rubboli A, Trevisani F, Cancellieri C, Ligabue A, Baradini M, et al. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. J Hepatol 1991;12:207–16.
   PubMed Web of Science ®Google Scholar
• Epstein SK, Ciubotaru RL, Zilberberg MD, Kaplan LM, Jacoby C, Freeman R, et al. Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci 1998;43: 1701–7.
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. Arterial compliance in patients with cirrhosis. High stroke volume/pulse pressure ratio as an index of elevated arterial compliance. Am J Physiol 2000.
   Google Scholar
• Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996;24:451–9.
   PubMed Web of Science ®Google Scholar
• Ingles AC, Hernandez I, Garcia-Estan J, Quesada T, Carbonell LF. Limited cardiac preload reserve in conscious cirrhotic rats. Am J Physiol 1991;260:H1912–7.
   Google Scholar
• Wong F, Siu S, Liu P, Blendis LM. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Hepatology 2000;32:408A.
   Google Scholar
• Henriksen JH, Møller S, Ring-Larsen H, Christensen NJ. The sympathetic nervous system in liver disease. J Hepatol 1998; 29:328–41.
   PubMed Web of Science ®Google Scholar
• Pateron D, Beyne P, Laperche T, Logeard D, Lefilliatre P, Sogni P, et al. Elevated circulating cardiac troponin I in patients with cirrhosis [In Process Citation]. Hepatology 1999; 29:640–3.
   PubMed Web of Science ®Google Scholar
• Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, et al. Impaired responsiveness to angiotensin-II in experimental cirrhosis: role of nitric oxide. Hepatology 1993;18:367–72.
   PubMed Web of Science ®Google Scholar
• Bomzon A. Impaired responsiveness to angiotensin II in experimental cirrhosis. Hepatology 1994;20:266–7.
   PubMed Web of Science ®Google Scholar
• Moreau R, Hadengue A, Soupison T, Mechin G, Assous M, Roche-Sicot J, et al. Abnormal pressor response to vasopressin in patients with cirrhosis: evidence for impaired buffering mechanisms. Hepatology 1990;12:7–12.
   Google Scholar
• Polio J, Sieber CC, Lerner E, Groszmann RJ. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats. Hepatology 1993;18:128–36.
   PubMed Web of Science ®Google Scholar
• Wu ZY, Benoit JN. Vascular NE responsiveness in portal hypertension: role of portal pressure and portosystemic shunting. Am J Physiol 1994;266:H1162–8.
   Google Scholar
• Gerbes AL, Remien J, Jüngst D, Sauerbruch T, Paumgartner G. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1986;1: 1409–11.
   Google Scholar
• Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology 1996;110:1191–8.
   Google Scholar
• Zavecz JH, Bueno O, Maloney RE, O’Donnell JM, Roerig SC, Battarbee HD. Cardiac excitation-contraction coupling in the portal hypertensive rat. Am J Physiol Gastrointest L 2000;279: G28–39.
   Google Scholar
• Oliver MI, Miralles R, Rubiesprat J, Navarro X, Espadaler JM, Sola R, et al. Autonomic dysfunction in patients with nonalcoholic chronic liver disease. J Hepatol 1997;26:1242–8.
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Lavilla G, Laffi G, Vecchiarino S, Gambilonghi F, Gentilini P, et al. Autonomic regulation of heart rate and QT interval in nonalcoholic cirrhosis with ascites. Digestion 1997; 58:580–6.
   PubMed Web of Science ®Google Scholar
• Mohamed R, Forsey PR, Davies MK, Neuberger JM. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology 1996;23:1128–34.
   PubMed Web of Science ®Google Scholar
• Ryan J, Sudhir K, Jennings G, Esler M, Dudley F. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology 1993;105:1167–72.
   Google Scholar
• Dillon JF, Nolan J, Thomas H, Williams BC, Neilson JMM, Bouchier IAD, et al. The correction of autonomic dysfunction in cirrhosis by captopril. J Hepatol 1997;26:331–5.
   PubMed Web of Science ®Google Scholar
• Jaue DN, Ma ZH, Lee SS. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy. Hepatology 1997; 25:1361–5.
   Google Scholar
• Moreau R, Komaichi H, Kirstetter P, Ohsuga M, Cailmail S, Lebrec D. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. Gastroenterology 1994;106:1016–23.
   PubMed Web of Science ®Google Scholar
• Liu HQ, Lee SS. Cardiopulmonary dysfunction in cirrhosis. J Gastroenterol Hepatol 1999;14:600–8.
   PubMedGoogle Scholar
• Moreau R, Lebrec D. Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol 1995;22:370–6.
   PubMed Web of Science ®Google Scholar
• Day PC, James FWO, Butler JT, Campbell RWF. Q-T prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993;341:1423–8.
   PubMed Web of Science ®Google Scholar
• Bernardi M, Calandra S, Colantoni A, Trevisani F, Raimondo ML, Sica G, et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998; 27:28–34.
   PubMed Web of Science ®Google Scholar
• Pizcueta P, Pique JM, Fernandez M, Bosch J, Rodes J, Whittle BJR, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1909–15.
   PubMed Web of Science ®Google Scholar
• Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993;104:1750–4.
   PubMed Web of Science ®Google Scholar
• Sanchez-Rodriguez A, Criado M, Rodriguez-Lopez AM, Esteller A, Dearriba AM, Lopez-Novoa JM. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis. Clin Sci 1998;94:637–43.
   Google Scholar
• Saijyo T, Nomura M, Nakaya Y, Saito K, Ito S. Autonomic nervous system activity during infusion of L-arginine in patients with liver cirrhosis. Liver 1998;18:27–31.
   Google Scholar
• Van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol 1996;24:747–52.
   Google Scholar
• Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats [In Process Citation]. Gastroenterology 2000;118:937–44.
   Google Scholar
• Kelbæk H, Nielsen BM, Eriksen J, Rabøl A, Christensen NJ, Lund JO, et al. Left ventricular performance in alcoholic patients without chronic liver disease. Br Heart J 1987; 58:352–7.
   Google Scholar
• Fernandez-Sola J, Estruch R, Grau JM, Pare JC, Rubin E, Urbano-Marquez A. The relation of alcoholic myopathy to cardiomyopathy. Ann Int Med 1994;120:529–36.
   Google Scholar
• Harcombe AA, Ramsay L, Kenna JG, Koskinas J, Why HJ, Richardson PJ, et al. Circulating antibodies to cardiac proteinacetaldehyde adducts in alcoholic heart muscle disease. Clin Sci (Colch) 1995;88:263–8.
   Google Scholar
• Tevelthuis H, Jansen PGM, Oudemansvanstraaten HM, Vankamp GJ, Sturk A, Eijsman L, et al. Circulating endothelin in cardiac operations: influence of blood pressure and endotoxin. Ann Thorac Surg 1996;61:904–8.
   PubMedGoogle Scholar
• Green J, Better OS. Systemic hypotension and renal failure in obstructive jaundice: mechanistic and therapeutic aspects. J Am Soc Nephrol 1995;5:1853–71.
   PubMed Web of Science ®Google Scholar
• Ma ZH, Zhang YK, Huet PM, Lee SS. Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy. J Hepatol 1999;30: 485–91.
   PubMedGoogle Scholar
• Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000;140:111–20.
   Google Scholar
• Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000;6:S44–52.
   PubMed Web of Science ®Google Scholar